FindTrial
Sign In

Clinical study on clinical symptoms, imaging features and pathological features of lacrimal duct lymphoma

Clinical study on clinical symptoms, imaging features and pathological features of lacrimal duct lymphoma

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100050677
Enrollment
Unknown
Registered
2021-09-01
Start date
2021-09-10
Completion date
Unknown
Last updated
2022-05-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lacrimal duct lymphoma

Interventions

Case series:No

Sponsors

The Third Medical Center of PLA General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients with lacrimal duct lymphoma; 2. Have autonomy; 3. The patient who signed the consent form.

Exclusion criteria

Exclusion criteria: 1. Patients with lymphoma in other parts of the body at the same time; 2. Patients with unclear pathological types and incomplete data.

Design outcomes

Primary

MeasureTime frame
Clinical symptoms;Pathological classification;Imaging features;survival rate;—

Countries

China

Contacts

Public ContactBai Fang

The Third Medical Center of PLA General Hospital

baifang@301hospital.com.cn+86 18618249879

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026